Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alexey Maslyanskiy"'
Autor:
Valentina Myachikova, Igor Kudryavtsev, Artem Rubinstein, Arthur Aquino, Dmitry Isakov, Alexey Golovkin, Alexey Maslyanskiy
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 2, Pp 1177-1191 (2024)
Adult-onset Still’s disease (AOSD) is a complex systemic inflammatory disorder, categorized as an ‘IL-1 driven’ inflammasomapathy. Despite this, the interaction between T and B cells remains poorly understood. We conducted a study, enrolling 7
Externí odkaz:
https://doaj.org/article/e83c9a1ddf364f8e9745ee05db004c94
Autor:
Igor Kudryavtsev, Stanislava Benevolenskaya, Maria Serebriakova, Irina Grigor’yeva, Evgeniy Kuvardin, Artem Rubinstein, Alexey Golovkin, Olga Kalinina, Ekaterina Zaikova, Sergey Lapin, Alexey Maslyanskiy
Publikováno v:
Biomedicines, Vol 11, Iss 10, p 2778 (2023)
Currently, multiple studies have indicated that CD8+ T lymphocytes play a role in causing damage to the exocrine glands through acinar injury in primary Sjögren’s syndrome (pSS). The aim of this research was to assess the imbalance of circulating
Externí odkaz:
https://doaj.org/article/34d973ac775b4cf0aed83a4b7d9ec9df
Autor:
Valentina Myachikova, Olga Moiseeva, Alexandra Konradi, Sergey V. Lapin, Olga Tkachenko, Vladimir Nazarov, Eugen Feist, Alexey Maslyanskiy
Publikováno v:
Clinical and Experimental Rheumatology.
Adult-onset Still's disease (AOSD) is increasingly viewed as autoinflammatory disease associated with the so-called inflammasomopathy. Proinflammatory cytokines, such as IL-18 and IL-1β, processed through the inflammasome machinery, play an importan
Autor:
Stanley Cohen, Katie Tuckwell, Tamiko R. Katsumoto, Rui Zhao, Joshua Galanter, Chin Lee, Julie Rae, Balazs Toth, Nandhini Ramamoorthi, Jason A. Hackney, Alberto Berman, Nemanja Damjanov, Dmytro Fedkov, Slawomir Jeka, Leslie W. Chinn, Michael J. Townsend, Alyssa M. Morimoto, Mark C. Genovese, Alejandro Porto, Amelia Granel, Cecilia Asnal, Eduardo Fabian Mysler, Gladys Alicia Testa, Jose Luis Velasco Zamora, Jose Luis Cristian Moreno, Juan Pablo Gulin, Julio Hofman, Maria Rosa Ulla, Mirtha Sabelli, Pablo Alejandro Mannucci, Pablo Jorge Maid, Ana Cláudia Cauceglia Melazzi, Antônio Scafuto Scotton, Antônio Carlos Ximenes, Elisete Funes, Emerson Alves Gimenez, Flora Maria D’Andrea Marcolino, João Francisco Marques Neto, Mauro Waldemar Keiserman, Sebastião Cézar Radominski, Sônia Maria Alvarenga Anti Loduca Lima, Thaís Rohde Pavan, Valderílio Feijó Azevedo, Aneliya Koleva, Antoaneta Toncheva, Daniela Bichovska, Delina Ivanova, Dimitar Penev, Emil Dimitrov, Mariyana Mihaylova, Nadezhda Kapandjieva, Natalia Marinova, Tanya Aleksieva, Tanya Tsvetanova, Tsvetanka Petranova, Valentina Popova, Yuliy Spasov, Carlos Enrique Toro, Carlos Ernesto Arteaga Unigarro, Edwin Jauregui, Javier Dario Marquez Hernandez, Juan Jose Jaller Raad, Patricia Julieta Velez Sanchez, Chang Keun Lee, Chang‐Hee Suh, Eun Young Lee, Sang‐Heon Lee, Seong Wook Kang, Shin‐Seok Lee, Yun Jong Lee, Beatriz Elena Zazueta Montiel, Blanca Irma Pinzon de la O, Daniel Xibille Friedmann, Francisco Rosas Lopez, Isaura Rodriguez Torres, Luis Jara Quezada, Marco Maradiaga Ceceña, Miguel Cortes Hernandez, Miguel Saavedra Salinas, Agnieszka Rapa, Agnieszka Pawtel, Agnieszka Zielinska, Anna Dudek, Anna Rychlewska‐Hanczewska, Anna Strzelecka, Artur Racewicz, Barbara Stasiuk, Katarzyna Gruszecka, Krystyna Dworak, Tomasz Lowenhoff, Alexey Maslyanskiy, Andrey Rebrov, Diana Krechikova, Elena Zhugrova, Evgeniya Shmidt, Galina Matsievskaya, Irina Vinogradova, Irina Ler, Larisa Eliseeva, Ludmila Savina, Marina Stanislav, Mikhail Sandin, Natalia Zyablova, Nikolay Korshunov, Nino Mosesova, Oksana Polovnikova, Olga Nesmeyanova, Ruzana Samigullina, Sergey Moiseev, Sergey Noskov, Tatiana Raskina, Tatiana Popova, Valeriy Marchenko, Aleksandar Jovanovski, Bojana Stamenkovic, Gorica Ristic, Milijanka Lazarevic, Mirjana Veselinovic, Nada Vujasinovic‐Stupar, Predrag Ostojic, Andriy Yagensky, Andriy Gnylorybov, Dmytro Rekalov, Dmytroo Reshotko, Georgiy Dzyak, Iurii Gasanov, Ludmila Khimion, Mykola Stanislavchuk, Natalya Prykhodko, Oleg Nadashkevych, Oleg Bortkevych, Orest Abrahamovych, Roman Yatsyshyn, Samvel Turyanytsya, Svitlana Smiyan, Vadym Vizir, Victoria Kachur, Vira Tseluyko, Vladyslav Povoroznyuk, Volodymyr Koshlia, Vyacheslav Zhdan, Yurii Lymar, Yuriy Mostovoy, Angela Hawkes, Arthur Mabaquiao, Cong‐Qiu Chu, Craig Scoville, David Wyatt, Debra Weinstein, Harris McIlwain, Jacqueline Vo, Jeffrey Poiley, Joseph Forstot, Kathryn Dao, Mark Turner, Mark Genovese, Michael Borofsky, Paul Caldron, Philip Waller, Robert Levin, Samy Metyas, Scott Stein, Sharukh Shroff, Shirley Pang, Tauseef Syed, Vishala Chindalore
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Objective To evaluate fenebrutinib, an oral and highly selective noncovalent inhibitor of Bruton's tyrosine kinase (BTK), in patients with active rheumatoid arthritis (RA). Methods Patients with RA and an inadequate response to methotrexate (MTX) (co
Autor:
Anastasia Dmitruk, Alexey Maslyanskiy, Nataliya Klyaus, Stanislava Benevolenskaya, Dariya Kozlova, Dmitriy Vasilyev, Olga Karlina
Publikováno v:
Abstracts Accepted for Publication.
Background The determination of rheumatoid arthritis (RA) activity remains an important clinical task nowadays and it is a long and difficult process. There is no single approach to assess the activity of RA. The gold standard for evaluating RA activ
Autor:
E. P. Evdoshenko, Gavin Giovannoni, Ruth Dobson, Harald Kropshofer, David Leppert, Sergey V. Lapin, Joanne Topping, Alexey Maslyanskiy
Publikováno v:
Multiple Sclerosis and Related Disorders. 6:49-53
Objectives Clinical trials of IV-rituximab have proved successful. It is unclear whether intrathecal (IT)-rituximab is more efficacious at lower doses. We examine its effects on B-cell biomarkers. Methods MS patients received IT-rituximab at 3 time-p
Autor:
E. P. Evdoshenko, Amit Bar-Or, Skoromets Aa, Areg A. Totolian, Leonid Zaslavsky, Alexey Maslyanskiy, Sergey V. Lapin, Ruth Dobson
Publikováno v:
ISRN Neurology
Background. Mitoxantrone (MTX) and Rituximab (RTX) are successfully used for treatment of multiple sclerosis (MS) and can be combined to increase efficacy. Objective. We used MTX, RTX, and methylprednisolone in a single combined regiment and observed
Autor:
Christopher Ritchlin, Kim A. Papp, Andrej Bakulev, Winfried Graninger, William Taylor, Alexey Maslyanskiy, Iain McInnes, Luis Puig, Majed Khraishi, Rubén Queiro, Diamant Thaci, Ronald Vender, Alexey Kubanov
Publikováno v:
Lancet (London, England). 382(9894)
Many patients with psoriasis develop psoriatic arthritis, a chronic inflammatory disease that afflicts peripheral synovial, axial, and entheseal structures. The fully human monoclonal antibody ustekinumab is an efficacious treatment for moderate-to-s
Autor:
Alexey Maslyanskiy, Lapin, S. V., Kolesova, E. P., Penin, I. N., Cheshuina, M. D., Feist, E., Konradi, A. O.
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4eaac11f5dbcc66b9af68f1e6c2a8e08
http://www.scopus.com/inward/record.url?eid=2-s2.0-85006306767&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85006306767&partnerID=MN8TOARS